Pediapharm Inc. (CVE:PDP – Get Free Report) traded up 1.7% during trading on Wednesday . The stock traded as high as C$0.31 and last traded at C$0.30. 26,000 shares were traded during mid-day trading, a decline of 74% from the average session volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Price Performance
The company has a quick ratio of 0.71, a current ratio of 1.12 and a debt-to-equity ratio of 186.87. The company has a market capitalization of C$66.36 million and a price-to-earnings ratio of -4.11. The stock’s 50-day simple moving average is C$0.30 and its two-hundred day simple moving average is C$0.30.
Pediapharm Company Profile
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
See Also
- Five stocks we like better than Pediapharm
- Learn Technical Analysis Skills to Master the Stock Market
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- Canada Bond Market Holiday: How to Invest and Trade
- Generac Powers Ahead on the Electrification Mega-Trend
- Profitably Trade Stocks at 52-Week Highs
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
